KDR Biotech markets DASGIP Parallel Bioreactor Systems in Korea
DASGIP AG and KDR Biotech have signed a cooperation agreement. Thus, KDR Biotech will hold the exclusive distribution of DASGIP Parallel Bioreactor Systems on the Korean market. First sales are already initiated.
Chung, Youn-Taek, Managing Director of KDR Biotech, appreciates the partnership with DASGIP. “By including the DASGIP products into our portfolio we are aiming at winning first class labs in the areas of screening, strain and cell line development as well as process development as new customers”, states Chung, Youn-Taek.
Since 2007 DASGIP has been working on its expansion towards the Asian market. CEO Thomas Drescher points out: “With SCRUM, Tokyo, and Quintech, Singapore, we already are well represented in Japan and Singapore. Now we are happy to have found a reliable partner to enter the Korean market as well”.
Most read news
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

How cells rewrite their fate - The study could be the starting point for new methods to alter the molecular mechanisms of cancer development
Meige's_syndrome

Ready. Get set. Repress! - Stowers scientists manipulate the Set2 pathway to show how genes are faithfully copied
Superior_olivary_complex
BRAF-mutant mCRC phase III trial initiated - Merck partners with Array BioPharma and Pierre Fabre
On_the_Origin_of_Species

Distribution of COVID-19 vaccines with delivery drones - Wingcopter raises $22M to advance technology leadership in drone delivery, announces serial production
Hip_(anatomy)
Scientists identify FLT3 gene as a valid therapeutic target in acute myeloid leukemia
Gastric_bypass_surgery
